anymedi애니메디솔루션

Anymedi's shares have fallen sharply over the past year despite a large rally over three months, and the pack contains no financial statements.

Anymedi is a Korean KONEX-listed company making patient-specific 3D-printed surgical guides, implants and simulators built from CT or MRI scans using AI. At ₩246 per share, its market value is about ₩2.4B, and the stock is down 82% over one year and 46.5% over one month. The data pack has no annual or trailing financials and no valuation multiples, so the company's current profitability cannot be assessed from it.

What stands out

• The share price is down 82% over one year and 46.5% over one month, though it is up 316.9% over three months.
• The 52-week high is ₩2,585 and the low is shown as ₩0, which looks like a data gap rather than a real price.
• No annual or trailing financial statements, P/E, P/B or EV/EBITDA are included, so the business's earnings and balance sheet are not visible here.
• Recent filings mostly cover insider and 5%+ shareholding reports, plus a rights offering (paid-in capital increase) decided in April 2026 with results filed later that month.
• Over the last 20 days, retail investors were net buyers (about ₩929M), while institutions were net sellers (about ₩519M) and foreign ownership stands at 0%.
• Peers in the pack are much larger, with market caps from about ₩1.1T to ₩2.8T.

What to watch

• The terms and outcome of the April 2026 rights offering and any further share issuance, since it affects dilution.
• Insider and 5%+ holder share changes, given the recent cluster of filings in August 2026.
• The annual report and any interim results, which are needed to judge revenue, profit and cash position; none are in the pack yet.